Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2022 Aug;24(8):985-993.
doi: 10.1007/s11912-022-01260-w. Epub 2022 Apr 6.

Ependymoma: Evaluation and Management Updates

Roberta Rudà  1 , Francesco Bruno  1 , Alessia Pellerino  1 , Riccardo Soffietti  2
Affiliations
Review

Ependymoma: Evaluation and Management Updates

Roberta Rudà et al. Curr Oncol Rep. 2022 Aug.

Abstract

Purpose of review: To review state of art and relevant advances in the molecular genetics and management of ependymomas of children and adults.

Recent findings: Ependymomas may occur either in the brain or in the spinal cord. Compared with intracranial ependymomas, spinal ependymomas are less frequent and exhibit a better prognosis. The new WHO classification of CNS tumors of 2021 has subdivided ependymomas into different histomolecular subgroups with different outcome. The majority of studies have shown a major impact of extent of resection; thus, a complete resection must be performed, whenever possible, at first surgery or at reoperation. Conformal radiotherapy is recommended for grade 3 or incompletely resected grade II tumors. Proton therapy is increasingly employed especially in children to reduce the risk of neurocognitive and endocrine sequelae. Craniospinal irradiation is reserved for metastatic disease. Chemotherapy is not useful as primary treatment and is commonly employed as salvage treatment for patients failing surgery and radiotherapy. Standard treatments are still the mainstay of treatment: the discovery of new druggable pathways will hopefully increase the therapeutic armamentarium in the near future.

Keywords: Chemotherapy; Conformal radiotherapy; MYCN-amplified spinal ependymoma; Myxopapillary ependymoma; Posterior fossa A; Posterior fossa B; Posterior fossa ependymomas; Proton therapy; Spinal cord ependymomas; Stereotactic radiotherapy; Supratentorial ependymomas; Surgery; YAP-1 fusion-positive ependymoma; ZFTA fusion-positive ependymoma.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Ostrom QT, Patil N, Cioffi G, Waite K, Kruchko C, Barnholtz-Sloan JS. CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013–2017. Neuro Oncol. 2020;22(12 Suppl 2):iv1-iv96. - PMC - PubMed
    1. McGuire CS, Sainani KL, Fisher PG. Incidence patterns for ependymoma: a surveillance, epidemiology, and end results study. J Neurosurg. 2009;110(4):725–729. doi: 10.3171/2008.9.JNS08117. - DOI - PubMed
    1. Rudà R, Reifenberger G, Frappaz D, et al. EANO guidelines for the diagnosis and treatment of ependymal tumors. Neuro Oncol. 2018;20(4):445–456. doi: 10.1093/neuonc/nox166. - DOI - PMC - PubMed
    1. Wani K, Armstrong TS, Vera-Bolanos E, et al; Collaborative Ependymoma Research Network. A prognostic gene expression signature in infratentorial ependymoma. Acta Neuropathol. 2012;123(5):727–738. - PMC - PubMed
    1. Raghunathan A, Wani K, Armstrong TS, et al; Collaborative Ependymoma Research Network. Histological predictors of outcome in ependymoma are dependent on anatomic site within the central nervous system. Brain Pathol. 2013;23(5):584–594. - PMC - PubMed

Publication types

Supplementary concepts